Non Hodgkin Lymphoma News and Research

RSS
Cancer-related expenditures increase faster than any other area of health care: JAMA

Cancer-related expenditures increase faster than any other area of health care: JAMA

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

New research shows link between infection-related diseases and risk of cancer

New research shows link between infection-related diseases and risk of cancer

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

Study: Higher risk of NHL and Cholangiocarcinoma associated with HBV infection

Study: Higher risk of NHL and Cholangiocarcinoma associated with HBV infection

Cancer drug, antiviral agent can eradicate active virus infection and tumor: UNC School of Medicine

Cancer drug, antiviral agent can eradicate active virus infection and tumor: UNC School of Medicine

Common drug used to treat Burkitt lymphoma can activate EBV: Study

Common drug used to treat Burkitt lymphoma can activate EBV: Study

CT colonography screening identifies unsuspected cancer outside of colon

CT colonography screening identifies unsuspected cancer outside of colon

LLS increases maximum benefit for myeloma patients to $10,000

LLS increases maximum benefit for myeloma patients to $10,000

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

Canadian Cancer Society calls on the B.C. government to ban cosmetic use of pesticides

Scott & White's CRI launches two clinical trials targeting cancers

Scott & White's CRI launches two clinical trials targeting cancers

CD20 deficiency in humans results in impaired T cell-independent antibody responses

CD20 deficiency in humans results in impaired T cell-independent antibody responses

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Genentech terminates dacetuzumab collaboration agreement with Seattle Genetics

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

Researchers explore optimal induction therapies for managing blood cancer

Researchers explore optimal induction therapies for managing blood cancer

Micromet to present new results from its blinatumomab study at the ASH meeting

Micromet to present new results from its blinatumomab study at the ASH meeting

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Seattle Genetics commences phase I clinical trial of SGN-75 ADC for metastatic renal cell carcinoma

Pharmacyclics to present clinical updates and posters relating to PCI-24781 and PCI-32765

Pharmacyclics to present clinical updates and posters relating to PCI-24781 and PCI-32765

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research